CliffBio
small molecule

LEVOFLOXACIN

LEVOFLOXACIN

Loss of exclusivity—loss of exclusivity
CompanyBaxter Healthcare Corp →See this company's full patent-cliff portfolio

Drug detail

Brand nameLEVOFLOXACIN
Active ingredientLEVOFLOXACIN
StrengthEQ 500MG/20ML (EQ 25MG/ML)
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalJune 2013
Marketing statusDISCN

More from Baxter Healthcare Corp

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.